QRG CAPITAL MANAGEMENT, INC.

Position in NBIX — Neurocrine Biosciences Inc

CIK 1996454 BERWYN, PA

Position in NBIX

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$3,185,911

+$1,009,698 QoQ

Shares Held

18,903

+14.4% QoQ

Ownership

0.019%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#11

of 76 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Jun 30, 2026

QRG CAPITAL MANAGEMENT, INC. holds $23,691,979 across 10 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (13.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TAK	Takeda Pharmaceutical Co Ltd	372,752	$5,975,214
2	ZTS	Zoetis Inc.	54,575	$3,921,759
3	HLN	Haleon plc	383,552	$3,578,540
4	NBIX	Neurocrine Biosciences Inc This page	18,903	$3,185,911
5	TEVA	Teva Pharmaceutical Industries Ltd	89,078	$3,017,962
6	UTHR	UNITED THERAPEUTICS Corp	3,476	$1,883,401
7	VTRS	Viatris Inc	49,564	$787,076
8	RDY	Dr Reddys Laboratories Ltd	41,233	$597,466

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,185,911	18,903	+14.4%	Shares	Sole	2026-07-14
2026-03-31	$2,176,213	16,519	+1.9%	Shares	Sole	2026-04-27
2025-12-31	$2,299,631	16,214	-16.6%	Shares	Sole	2026-02-02
2025-09-30	$2,727,723	19,431	-13.9%	Shares	Sole	2025-10-28
2025-06-30	$2,838,205	22,581	+12.6%	Shares	Sole	2025-07-21
2025-03-31	$2,218,857	20,062	+7.1%	Shares	Sole	2025-04-17
2024-12-31	$2,556,918	18,732	+2.5%	Shares	Sole	2025-02-05
2024-09-30	$2,106,106	18,279	+3.2%	Shares	Sole	2024-10-30
2024-06-30	$2,438,135	17,710	+11.5%	Shares	Sole	2024-07-12
2024-03-31	$2,189,893	15,878	+9.3%	Shares	Sole	2024-05-07
2023-12-31	$1,913,945	14,526	+13.1%	Shares	Sole	2024-02-07
2023-09-30	$1,444,612	12,841	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.